Atlas Trials

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

Clinical trial NCT05192889 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05192889
Sponsor
St. Jude Children's Research Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Refractory Acute Lymphoblastic LeukemiaRelapsed Acute Lymphoblastic Leukemia
Start date
2022-08-25
Primary completion
2024-06-13
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.